Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hovland, A. R.
Right arrow Articles by Horwitz, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hovland, A. R.
Right arrow Articles by Horwitz, K. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 10, 5455-5460, March 6, 1998

An N-terminal Inhibitory Function, IF, Suppresses Transcription by the A-isoform but Not the B-isoform of Human Progesterone Receptors

Alicia Rudie Hovland, Roger L. Powell, Glenn S. Takimoto, Lin Tung, and Kathryn B. Horwitz

From the Departments of Medicine and Pathology and the Molecular Biology Program, University of Colorado Health Sciences Center, Denver, Colorado 80262

The B-isoform of human progesterone receptors (PR) contains three activation functions (AF3, AF1, and AF2), two of which (AF1 and AF2) are shared with the A-isoform. AF3 is in the B-upstream segment (BUS), the far N-terminal 164 amino acids of B-receptors; AF1 is in the 392-amino acid N-terminal region common to both receptors; and AF2 is in the C-terminal hormone binding domain. B-receptors are usually stronger transactivators than A-receptors due to transcriptional synergism between AF3 and one of the two downstream AFs. We now show that the N terminus of PR common to both isoforms contains an inhibitory function (IF) located in a 292-amino acid segment lying upstream of AF1. IF represses the activity of A-receptors but is not inhibitory in the context of B-receptors due to constraints imparted by BUS. As a result, IF inhibits AF1 or AF2 but not AF3, regardless of the position of IF relative to BUS. IF is functionally independent and strongly represses transcription when it is fused upstream of estrogen receptors. These data demonstrate the existence of a novel, transferable inhibitory function, mapping to the PR N terminus, which begins to assign specific roles to this large undefined region.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Samalecos and B. Gellersen
Systematic Expression Analysis and Antibody Screening Do Not Support the Existence of Naturally Occurring Progesterone Receptor (PR)-C, PR-M, or Other Truncated PR Isoforms
Endocrinology, November 1, 2008; 149(11): 5872 - 5887.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. A. Molenda-Figueira, S. D. Murphy, K. L. Shea, N. K. Siegal, Y. Zhao, J. G. Chadwick Jr., L. A. Denner, and M. J. Tetel
Steroid Receptor Coactivator-1 from Brain Physically Interacts Differentially with Steroid Receptor Subtypes
Endocrinology, October 1, 2008; 149(10): 5272 - 5279.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. McGowan, A. J. Russell, V. Boonyaratanakornkit, D. N. Saunders, G. M. Lehrbach, C. M. Sergio, E. A. Musgrove, D. P. Edwards, and R. L. Sutherland
Progestins Reinitiate Cell Cycle Progression in Antiestrogen-Arrested Breast Cancer Cells through the B-Isoform of Progesterone Receptor
Cancer Res., September 15, 2007; 67(18): 8942 - 8951.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Georgiakaki, N. Chabbert-Buffet, B. Dasen, G. Meduri, S. Wenk, L. Rajhi, L. Amazit, A. Chauchereau, C. W. Burger, L. J. Blok, et al.
Ligand-Controlled Interaction of Histone Acetyltransferase Binding to ORC-1 (HBO1) with the N-Terminal Transactivating Domain of Progesterone Receptor Induces Steroid Receptor Coactivator 1-Dependent Coactivation of Transcription
Mol. Endocrinol., September 1, 2006; 20(9): 2122 - 2140.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
W. Pei, C. G Bellows, Y. Jia, and J. N M Heersche
Effect of age on progesterone receptor expression, and osteoprogenitor proliferation and differentiation in female rat vertebral cell populations.
J. Endocrinol., August 1, 2006; 190(2): 261 - 270.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. K. Mani, A. M. Reyna, J. Z. Chen, B. Mulac-Jericevic, and O. M. Conneely
Differential Response of Progesterone Receptor Isoforms in Hormone-Dependent and -Independent Facilitation of Female Sexual Receptivity
Mol. Endocrinol., June 1, 2006; 20(6): 1322 - 1332.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke
Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells
Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Huang, X. Li, C. A. Maguire, R. Hilf, R. A. Bambara, and M. Muyan
Binding of Estrogen Receptor {beta} to Estrogen Response Element in Situ Is Independent of Estradiol and Impaired by Its Amino Terminus
Mol. Endocrinol., November 1, 2005; 19(11): 2696 - 2712.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Pascual-Le Tallec and M. Lombes
The Mineralocorticoid Receptor: A Journey Exploring Its Diversity and Specificity of Action
Mol. Endocrinol., September 1, 2005; 19(9): 2211 - 2221.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
B. Mulac-Jericevic and O. M Conneely
Reproductive tissue selective actions of progesterone receptors
Reproduction, August 1, 2004; 128(2): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Pascual-Le Tallec, O. Kirsh, M.-C. Lecomte, S. Viengchareun, M.-C. Zennaro, A. Dejean, and M. Lombes
Protein Inhibitor of Activated Signal Transducer and Activator of Transcription 1 Interacts with the N-Terminal Domain of Mineralocorticoid Receptor and Represses Its Transcriptional Activity: Implication of Small Ubiquitin-Related Modifier 1 Modification
Mol. Endocrinol., December 1, 2003; 17(12): 2529 - 2542.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Mulac-Jericevic, J. P. Lydon, F. J. DeMayo, and O. M. Conneely
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
PNAS, August 19, 2003; 100(17): 9744 - 9749.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-L. Zhang, D. Zhang, F. J. Michel, J. L. Blum, F. A. Simmen, and R. C. M. Simmen
Selective Interactions of Kruppel-like Factor 9/Basic Transcription Element-binding Protein with Progesterone Receptor Isoforms A and B Determine Transcriptional Activity of Progesterone-responsive Genes in Endometrial Epithelial Cells
J. Biol. Chem., June 6, 2003; 278(24): 21474 - 21482.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Ballare, M. Uhrig, T. Bechtold, E. Sancho, M. Di Domenico, A. Migliaccio, F. Auricchio, and M. Beato
Two Domains of the Progesterone Receptor Interact with the Estrogen Receptor and Are Required for Progesterone Activation of the c-Src/Erk Pathway in Mammalian Cells
Mol. Cell. Biol., March 15, 2003; 23(6): 1994 - 2008.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Kumar and E. B. Thompson
Transactivation Functions of the N-Terminal Domains of Nuclear Hormone Receptors: Protein Folding and Coactivator Interactions
Mol. Endocrinol., January 1, 2003; 17(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Abdel-Hafiz, G. S. Takimoto, L. Tung, and K. B. Horwitz
The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression
J. Biol. Chem., September 6, 2002; 277(37): 33950 - 33956.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. E. Wardell, V. Boonyaratanakornkit, J. S. Adelman, A. Aronheim, and D. P. Edwards
Jun Dimerization Protein 2 Functions as a Progesterone Receptor N-Terminal Domain Coactivator
Mol. Cell. Biol., August 1, 2002; 22(15): 5451 - 5466.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Matsui, M. Sakari, T. Sato, A. Murayama, I. Takada, M. Kim, K.-i. Takeyama, and S. Kato
Transcriptional regulation of the mouse steroid 5{alpha}-reductase type II gene by progesterone in brain
Nucleic Acids Res., March 15, 2002; 30(6): 1387 - 1393.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
J. Biol. Chem., February 8, 2002; 277(7): 5209 - 5218.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Christian, Y. Pohnke, R. Kempf, B. Gellersen, and J. J. Brosens
Functional Association of PR and CCAAT/Enhancer-Binding Protein {beta} Isoforms: Promoter-Dependent Cooperation between PR-B and Liver-Enriched Inhibitory Protein, or Liver-Enriched Activatory Protein and PR-A in Human Endometrial Stromal Cells
Mol. Endocrinol., January 1, 2002; 16(1): 141 - 154.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
O. M. Conneely, B. Mulac-Jericevic, F. DeMayo, J. P. Lydon, and B. W. O'Malley
Reproductive Functions of Progesterone Receptors
Recent Prog. Horm. Res., January 1, 2002; 57(1): 339 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Tung, T. Shen, M. G. Abel, R. L. Powell, G. S. Takimoto, C. A. Sartorius, and K. B. Horwitz
Mapping the Unique Activation Function 3 in the Progesterone B-receptor Upstream Segment. TWO LXXLL MOTIFS AND A TRYPTOPHAN RESIDUE ARE REQUIRED FOR ACTIVITY
J. Biol. Chem., October 19, 2001; 276(43): 39843 - 39851.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Shen, K. B. Horwitz, and C. A. Lange
Transcriptional Hyperactivity of Human Progesterone Receptors Is Coupled to Their Ligand-Dependent Down-Regulation by Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Serine 294
Mol. Cell. Biol., September 15, 2001; 21(18): 6122 - 6131.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. Pieber, V. C. Allport, F. Hills, M. Johnson, and P. R. Bennett
Interactions between progesterone receptor isoforms in myometrial cells in human labour
Mol. Hum. Reprod., September 1, 2001; 7(9): 875 - 879.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P A Mote, J F Johnston, T Manninen, P Tuohimaa, and C L Clarke
Detection of progesterone receptor forms A and B by immunohistochemical analysis
J. Clin. Pathol., August 1, 2001; 54(8): 624 - 630.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. M. Conneely
Perspective: Female Steroid Hormone Action
Endocrinology, June 1, 2001; 142(6): 2194 - 2199.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Gao, J. Mazella, M. Tang, and L. Tseng
Ligand-Activated Progesterone Receptor Isoform hPR-A Is a Stronger Transactivator Than hPR-B for the Expression of IGFBP-1 (Insulin-Like Growth Factor Binding Protein-1) in Human Endometrial Stromal Cells
Mol. Endocrinol., December 1, 2000; 14(12): 1954 - 1961.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
R. Métivier, F. G. Petit, Y. Valotaire, and F. Pakdel
Function of N-Terminal Transactivation Domain of the Estrogen Receptor Requires a Potential {alpha}-Helical Structure and Is Negatively Regulated by the A Domain
Mol. Endocrinol., November 1, 2000; 14(11): 1849 - 1871.
[Abstract] [Full Text]


Home page
ScienceHome page
B. Mulac-Jericevic, R. A. Mullinax, F. J. DeMayo, J. P. Lydon, and O. M. Conneely
Subgroup of Reproductive Functions of Progesterone Mediated by Progesterone Receptor-B Isoform
Science, September 8, 2000; 289(5485): 1751 - 1754.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
P. H. Giangrande, E. A. Kimbrel, D. P. Edwards, and D. P. McDonnell
The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding
Mol. Cell. Biol., May 1, 2000; 20(9): 3102 - 3115.
[Abstract] [Full Text]


Home page
CirculationHome page
Y. K. Hodges, L. Tung, X.-D. Yan, J. D. Graham, K. B. Horwitz, and L. D. Horwitz
Estrogen Receptors {alpha} and {beta} : Prevalence of Estrogen Receptor {beta} mRNA in Human Vascular Smooth Muscle and Transcriptional Effects
Circulation, April 18, 2000; 101(15): 1792 - 1798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Bain, M. A. Franden, J. L. McManaman, G. S. Takimoto, and K. B. Horwitz
The N-terminal Region of the Human Progesterone A-receptor. STRUCTURAL ANALYSIS AND THE INFLUENCE OF THE DNA BINDING DOMAIN
J. Biol. Chem., March 15, 2000; 275(10): 7313 - 7320.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
U. Ottander, K. Hosokawa, K. Liu, A. Bergh, T. Ny, and J. I. Olofsson
A Putative Stimulatory Role of Progesterone Acting via Progesterone Receptors in the Steroidogenic Cells of the Human Corpus Luteum
Biol Reprod, March 1, 2000; 62(3): 655 - 663.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
D. L. Clemm, L. Sherman, V. Boonyaratanakornkit, W. T. Schrader, N. L. Weigel, and D. P. Edwards
Differential Hormone-Dependent Phosphorylation of Progesterone Receptor A and B Forms Revealed by a Phosphoserine Site-Specific Monoclonal Antibody
Mol. Endocrinol., January 1, 2000; 14(1): 52 - 65.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
E. M. McGowan and C. L. Clarke
Effect of Overexpression of Progesterone Receptor A on Endogenous Progestin-Sensitive Endpoints in Breast Cancer Cells
Mol. Endocrinol., October 1, 1999; 13(10): 1657 - 1671.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
Q. Lan, K. Hiruma, X. Hu, M. Jindra, and L. M. Riddiford
Activation of a Delayed-Early Gene Encoding MHR3 by the Ecdysone Receptor Heterodimer EcR-B1-USP-1 but Not by EcR-B1-USP-2
Mol. Cell. Biol., July 1, 1999; 19(7): 4897 - 4906.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. J. Tetel, P. H. Giangrande, S. A. Leonhardt, D. P. McDonnell, and D. P. Edwards
Hormone-Dependent Interaction between the Amino- and Carboxyl-Terminal Domains of Progesterone Receptor in Vitro and in Vivo
Mol. Endocrinol., June 1, 1999; 13(6): 910 - 924.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement